Abstract
The article discusses certain aspects of the relationship between neurological diseases and metabolic disorders that are extremely relevant in connection with the pandemic spread of obesity. The pathogenesis of damage to the nervous system (NS) is considered in detail. The influence of the main metabolic factors on the development of cerebrovascular diseases (CVD), incl. neuroinflammation, changes in hemostasis, etc. is demonstrated. The problem of the development of cognitive dysfunction against the background of obesity due to the formation of atrophic processes in brain structures is highlighted. Modern possibilities of evaluation and modulation of eating behavior due to brain stimulation using functional magnetic resonance imaging (fMRI) and navigational rhythmic transcranial magnetic stimulation (rTMS) are described.The problem of cerebrometabolic health is presented as a continuum of metabolic and cerebral disturbances. The mechanisms of interaction between the two most important systems of the body allow us to consider the changes that occur in them as an integral neuroendocrine alteration.
Topics

No keywords indexed for this article. Browse by subject →

References
59
[1]
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
New England Journal of Medicine 10.1056/nejmoa1614362
[2]
Mokrysheva NG. Fighting obesity as a direction of national health care development. Obe Metab. 2022;19(1):4-6. (In Russ.). doi: https://doi.org/10.14341/omet12865 10.14341/omet12865
[3]
Alferova VI, Mustafina S V. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obe Metab. 2022;19(1):96-105. (In Russ.). doi: https://doi.org/10.14341/omet12809 10.14341/omet12809
[4]
Prevalence of the risk factors of cerebrovascular disorders in the capital city residents aged 40-59: a clinical and epidemiological study. Annals of Clinical and Experimental Neurology. 2016;10(4):11-19. (In Russ.). doi: https://doi.org/10.17816/psaic13
[5]
Sinha R. Role of addiction and stress neurobiology on food intake and obesity. Biol Psychol. 2018;131:5-13. doi: https://doi.org/10.1016/j.biopsycho.2017.05.001 10.1016/j.biopsycho.2017.05.001
[6]
Candler T, Kuhnen P, Prentice AM, Silver M. Epigenetic regulation of POMC; implications for nutritional programming, obesity and metabolic disease. Front Neuroendocrinol. 2019;54:100773. doi: https://doi.org/10.1016/j.yfrne.2019.100773 10.1016/j.yfrne.2019.100773
[7]
Goit RK, Taylor AW, Lo ACY. The central melanocortin system as a treatment target for obesity and diabetes: A brief overview. Eur J Pharmacol. 2022;924:174956. doi: https://doi.org/10.1016/j.ejphar.2022.174956 10.1016/j.ejphar.2022.174956
[8]
Yang D, Hou X, Yang G, et al. Effects of the POMC System on Glucose Homeostasis and Potential Therapeutic Targets for Obesity and Diabetes. Diabetes, Metab Syndr Obes Targets Ther. 2022;Volume 15:2939-2950. doi: https://doi.org/10.2147/DMSO.S380577 10.2147/dmso.s380577
[9]
Ono H. Molecular Mechanisms of Hypothalamic Insulin Resistance. Int J Mol Sci. 2019;20(6):1317. doi: https://doi.org/10.3390/ijms20061317 10.3390/ijms20061317
[10]
Uranga RM, Keller JN. The Complex Interactions Between Obesity, Metabolism and the Brain. Front Neurosci. 2019;13. doi: https://doi.org/10.3389/fnins.2019.00513 10.3389/fnins.2019.00513
[11]
O'Brien PD, Hinder LM, Callaghan BC, Feldman EL. Neurological consequences of obesity. Lancet Neurol. 2017;16(6):465-477. doi: https://doi.org/10.1016/S1474-4422(17)30084-4 10.1016/s1474-4422(17)30084-4
[12]
Chumakova GA, Ott A V., Veselovskaya NG, Gritsenko O V., Shenkova NN. PATHOGENETIC MECHANISMS OF LEPTIN RESISTANCE. Russ J Cardiol. 2015;(4):107. (In Russ.). doi: https://doi.org/10.15829/1560-4071-2015-4-107-110 10.15829/1560-4071-2015-4-107-110
[13]
Banks WA. Leptin and the Blood-Brain Barrier: Curiosities and Controversies. In: Comprehensive Physiology. Wiley; 2021:2351-2369. doi: https://doi.org/10.1002/cphy.c200017 10.1002/cphy.c200017
[14]
Lavoie O, Michael NJ, Caron A. A critical update on the leptin-melanocortin system. J Neurochem. 2023;165(4):467-486. doi: https://doi.org/10.1111/jnc.15765 10.1111/jnc.15765
[15]
Zeltser LM, Seeley RJ, Tschop MH. Synaptic plasticity in neuronal circuits regulating energy balance. Nat Neurosci. 2012. doi: https://doi.org/10.1038/nn.3219 10.1038/nn.3219
[16]
Quaresma PGF, Wasinski F, Mansano NS, et al. Leptin Receptor Expression in GABAergic Cells is Not Sufficient to Normalize Metabolism and Reproduction in Mice. Endocrinology. 2021;162(11). doi: https://doi.org/10.1210/endocr/bqab168 10.1210/endocr/bqab168
[17]
Comeras LB, Herzog H, Tasan RO. Neuropeptides at the crossroad of fear and hunger: a special focus on neuropeptide Y. Ann N Y Acad Sci. 2019;1455(1):59-80. doi: https://doi.org/10.1111/nyas.14179 10.1111/nyas.14179
[18]
Sousa D, Lopes E, Rosendo-Silva D, Matafome P. The Bidirectional Relationship of NPY and Mitochondria in Energy Balance Regulation. Biomedicines. 2023;11(2):446. doi: https://doi.org/10.3390/biomedicines11020446 10.3390/biomedicines11020446
[19]
Marcos JL, Olivares-Barraza R, Ceballo K, et al. Obesogenic Diet-Induced Neuroinflammation: A Pathological Link between Hedonic and Homeostatic Control of Food Intake. Int J Mol Sci. 2023;24(2):1468. doi: https://doi.org/10.3390/ijms24021468 10.3390/ijms24021468
[20]
Bandala C, Cardenas-Rodnguez N, Reyes-Long S, et al. Trends in Gliosis in Obesity, and the Role of Antioxidants as a Therapeutic Alternative. Antioxidants. 2022;11(10):1972. doi: https://doi.org/10.3390/antiox11101972 10.3390/antiox11101972
[21]
Sewaybricker LE, Huang A, Chandrasekaran S, Melhorn SJ, Schur EA. The Significance of Hypothalamic Inflammation and Gliosis for the Pathogenesis of Obesity in Humans. Endocr Rev. 2023. doi: https://doi.org/10.1210/endrev/bnac023 10.1210/endrev/bnac023
[22]
Zhang Q, Jin K, Chen B, et al. Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation. Front Neurosci. 2022;16. doi: https://doi.org/10.3389/fnins.2022.884579 10.3389/fnins.2022.884579
[23]
Maurizi G, Della Guardia L, Maurizi A, Poloni A. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol. 2018;233(1):88-97. doi: https://doi.org/10.1002/jcp.25855 10.1002/jcp.25855
[24]
Lin Y, Qu L, Wu J, Pu M, Huang Y, Cao Y. Identification of Adipogenesis Subgroups and Immune Infiltration Characteristics in Diabetic Peripheral Neuropathy. Xu Z, ed. J Immunol Res. 2023;2023:1-15. doi: https://doi.org/10.1155/2023/3673094 10.1155/2023/3673094
[25]
Lipids and peripheral neuropathy

Zohaib Iqbal, Bilal Bashir, Maryam Ferdousi et al.

Current Opinion in Lipidology 10.1097/mol.0000000000000770
[26]
Rumora AE, Savelieff MG, Sakowski SA, Feldman EL. Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes. In: International Review of Neurobiology. 2019:127-176. doi: https://doi.org/10.1016/bs.irn.2019.05.002 10.1016/bs.irn.2019.05.002
[27]
Marini S, Merino J, Montgomery BE, et al. Mendelian Randomization Study of Obesity and Cerebrovascular Disease. Ann Neurol. 2020;87(4):516-524. doi: https://doi.org/10.1002/ana.25686 10.1002/ana.25686
[28]
Letra L, Sena C. Cerebrovascular Disease: Consequences of Obesity-Induced Endothelial Dysfunction. In: Advances in Neurobiology. ; 2017:163-189. doi: https://doi.org/10.1007/978-3-319-63260-5_7 10.1007/978-3-319-63260-5_7
[29]
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Valery L Feigin, Benjamin A Stark, Catherine Owens Johnson et al.

The Lancet Neurology 10.1016/s1474-4422(21)00252-0
[30]
Gorelick PB. The global burden of stroke: persistent and disabling. Lancet Neurol. 2019;18(5):417-418. doi: https://doi.org/10.1016/S1474-4422(19)30030-4 10.1016/s1474-4422(19)30030-4
[31]
Kim MS, Kim WJ, Khera A V., et al. Association between adiposity and cardiovascular outcomes: An umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J. 2021. doi: https://doi.org/10.1093/eurheartj/ehab454 10.1093/eurheartj/ehab454
[32]
Horn JW, Feng T, M0rkedal B, et al. Obesity and Risk for First Ischemic Stroke Depends on Metabolic Syndrome: The HUNT Study. Stroke. 2021;52(11):3555-3561. doi: https://doi.org/10.1161/STROKEAHA.120.033016 10.1161/strokeaha.120.033016
[33]
Kim P-J, Kim C, Lee S-H, et al. Another Look at Obesity Paradox in Acute Ischemic Stroke: Association Rule Mining. J Pers Med. 2021;12(1):16. doi: https://doi.org/10.3390/jpm12010016 10.3390/jpm12010016
[34]
Tanashyan ММ, Antonova KV, Lagoda OV, Shabalina АА. Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus. Annals of Clinical and Experimental Neurology. 2021;15(3):5-14. (in Russ). doi: https://doi.org/10.54101/ACEN.2021.3.1 10.54101/acen.2021.3.1
[35]
Chavakis T, Alexaki VI, Ferrante AW. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat Immunol. 2023;24(5):757-766. doi: https://doi.org/10.1038/s41590-023-01479-0 10.1038/s41590-023-01479-0
[36]
Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. doi: https://doi.org/10.1016/j.biopha.2021.111315 10.1016/j.biopha.2021.111315
[37]
Tanashyan MM, Antonova KV., Raskurazhev AA, Lagoda O V., Shabalina AA, Romantsova TI. Cerebrovascular disorders and glucolipotoxicity. Ann Clin Exp Neurol. 2020;14(1):17-24. (in Russ.). doi: https://doi.org/10.25692/ACEN.2020.1.2
[38]
Ortega FB, Lavie CJ, Blair SN. Obesity and Cardiovascular Disease. Circ Res. 2016;118(11):1752-1770. doi: https://doi.org/10.1161/CIRCRESAHA.115.306883 10.1161/circresaha.115.306883
[39]
Chumakova GA, Kuznetsova TY, Druzhilov MA, Veselovskaya NG. Obesity induced hypertension: The main pathophysiologic mechanisms. Arterial Hypertension. 2021, 3:260-268. (in Russ.). doi: https://doi.org/10.18705/1607-419X-2021-27-3-260-268 10.18705/1607-419x-2021-27-3-260-268
[40]
Antonova KV, Tanashyan MM, Shabalina AA, et al. Hemostasis in patients with type 2 diabetes mellitus and obesity in acute and chronic cerebrovascular pathology. Thrombosis, Hemostasis and Rheology. 2020;82(2):60-67 (in Russ). doi: https://doi.org/10.25555/THR.2020.2.0919 10.25555/thr.2020.2.0919
[41]
Tanashyan M. Cerebrovascular Pathology and Metabolic Syndrome. LLC «AST 345»; 2019. (in Russ.). doi: https://doi.org/10.33901/978-5-6041430-2-5-2019-1-370 10.33901/978-5-6041430-2-5-2019-1-370
[42]
Prospective Studies Collaboration. Body-mass index and causespecific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096. doi: https://doi.org/10.1016/S0140-6736(09)60318-4 10.1016/s0140-6736(09)60318-4
[43]
Tanashyan MM, Antonova KV, Lagoda OV, et al. Ozhirenie i protrombogennoe sostoyanie krovi u pacientov s cerebrovaskulyarny'mi zabolevaniyami // Thrombosis, Hemostasis and Rheology. 2023;(3):53-62 (in Russ.). doi: https://doi.org/10.25555/THR.2023.3.1069 10.25555/thr.2023.3.1069
[44]
Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Heal. 2022;7(2):e105-e125. doi: https://doi.org/10.1016/S2468-2667(21)00249-8 10.1002/alz.051496
[45]
Stillman CM, Weinstein AM, Marsland AL, Gianaros PJ, Erickson KI. Body-Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging. Front Aging Neurosci. 2017;9. doi: https://doi.org/10.3389/fnagi.2017.00115 10.3389/fnagi.2017.00115
[46]
Raji CA, Ho AJ, Parikshak NN, et al. Brain structure and obesity. Hum Brain Mapp. 2010;31(3):353-364. doi: https://doi.org/10.1002/hbm.20870 10.1002/hbm.20870
[47]
Medic N, Ziauddeen H, Ersche KD, et al. Increased body mass index is associated with specific regional alterations in brain structure. Int J Obes. 2016;40(7):1177-1182. doi: https://doi.org/10.1038/ijo.2016.42 10.1038/ijo.2016.42
[48]
Abdalla MMI, Azzani M, Atroosh W, Anbazhagan D, Kumarasamy V. The association between mental health and obesity in postmenopausal women: A systematic review. Endocr Regul. 2022;56(4):295-310. doi: https://doi.org/10.2478/enr-2022-0032 10.2478/enr-2022-0032
[49]
Singh-Manoux A, Dugravot A, Shipley M, et al. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimer's Dement. 2018;14(2):178-186. doi: https://doi.org/10.1016/j.jalz.2017.06.2637 10.1016/j.jalz.2017.06.2637
[50]
Kivimaki M, Luukkonen R, Batty GD, et al. Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals. Alzheimer's Dement. 2018;14(5):601-609. doi: https://doi.org/10.1016/j.jalz.2017.09.016 10.1016/j.jalz.2017.09.016

Showing 50 of 59 references

Cited By
13
Cerebrometabolic Health

M. M. Tanashyan, K. V. Antonova · 2025

Annals of Clinical and Experimental...
Metabolic predictors of ischemic stroke in young adults

Maria S. Ponomareva, Larisa A. Shchepankevich · 2025

Annals of Clinical and Experimental...
Metrics
13
Citations
59
References
Details
Published
Mar 06, 2024
Vol/Issue
21(1)
Pages
68-78
License
View
Cite This Article
K. V. Antonova, M. M. Tanashyan, A. A. Raskurazhev, et al. (2024). Obesity and the nervous system. Obesity and metabolism, 21(1), 68-78. https://doi.org/10.14341/omet13019
Related

You May Also Like

Immunometabolism and metainflammation in obesity

Tatiana R. Romantsova, Yulia P. Sych · 2019

47 citations

Insulin resistance in obesity: pathogenesis and effects

Evgenia A. Lavrenova, Oxana M. Drapkina · 2020

36 citations

Adipose tissue: colors, depots and functions

T. I. Romantsova · 2021

25 citations